This inventor holds 4 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Janssen Biotech, Inc.. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wayne, PA (US) (2021 - 2022)
- Spring House, PA (US) (2023)
Company Filing History:
Years Active: 2021-2023
Title: Mark Richter: Innovator in STING Modulation
Introduction
Mark Richter is a notable inventor based in Wayne, PA (US), recognized for his contributions to the field of biotechnology. He has been granted a total of four patents, showcasing his innovative approach to addressing complex medical challenges.
Latest Patents
Richter's latest patents focus on cyclic dinucleotides as STING agonists. These patents disclose compounds, compositions, and methods for treating diseases, syndromes, or disorders that are influenced by the modulation of STING. The compounds are represented by specific formulas, detailing the structural components involved in their efficacy.
Career Highlights
Mark Richter is currently employed at Janssen Biotech, Inc., where he continues to advance his research and development efforts. His work is pivotal in the exploration of new therapeutic avenues that leverage the modulation of STING for improved health outcomes.
Collaborations
Richter collaborates with esteemed colleagues, including Stuart Emanuel and Peter J Connolly, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Mark Richter's work in the field of STING modulation exemplifies the impact of innovative thinking in biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile